ArticlePLoS neglected tropical diseases2026
Predictors of severe strongyloidiasis and mortality in hospitalized patients from Southern Thailand.
Article in PLoS neglected tropical diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundStrongyloidiasis is a neglected tropical infection that can progress to life-threatening disease in immunocompromised hosts. However, predictors of severe disease and mortality remain incompletely defined, particularly in endemic regions. We aimed to identify clinical predictors of severe strongyloidiasis and 30-day mortality among hospitalized patients in southern Thailand.
methodsWe conducted a 16-year retrospective cohort study of hospitalized patients aged ≥13 years with laboratory-confirmed Strongyloides stercoralis infection at a tertiary-care hospital between 2009 and 2025. Severe strongyloidiasis was defined by larval detection in extraintestinal or respiratory specimens or compatible clinical manifestations involving multiple organ systems with infectious complications. Multivariable logistic regression was used to identify predictors of severe disease and mortality.
resultsAmong 735 patients, 47 (6.4%) had severe strongyloidiasis. Corticosteroid exposure within 60 days was independently associated with severe disease (adjusted odds ratio [aOR] 3.25, 95% CI 1.65-6.73), whereas eosinophilia (absolute eosinophil count ≥500 cells/µL) was associated with lower odds (aOR 0.41, 95% CI 0.19-0.82). Bacteremia was more frequent in severe cases (38.3% vs 4.1%, p < 0.001), predominantly due to gram-negative organisms. Severe strongyloidiasis was associated with higher 30-day mortality (38.3% vs 14.0%, p < 0.001). In multivariable analysis, increasing age (aOR 1.22 per 10-year increase), higher National Early Warning Score (aOR 1.41 per point), and bacteremia (aOR 3.38) were independently associated with mortality, whereas eosinophilia was associated with lower odds of death and severe strongyloidiasis itself was not.
conclusionsCorticosteroid exposure was the strongest predictor of severe strongyloidiasis, while eosinophilia was protective. Mortality was driven primarily by bacteremia and physiologic instability. Early recognition and treatment are essential to improve outcomes in endemic settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.